scispace - formally typeset
A

Adam Torbicki

Researcher at Medical University of Warsaw

Publications -  349
Citations -  104144

Adam Torbicki is an academic researcher from Medical University of Warsaw. The author has contributed to research in topics: Pulmonary hypertension & Pulmonary embolism. The author has an hindex of 83, co-authored 334 publications receiving 91421 citations. Previous affiliations of Adam Torbicki include Erasmus University Rotterdam & New York Academy of Medicine.

Papers
More filters
Journal ArticleDOI

Acute and chronic dissection of pulmonary artery: new challenges in pulmonary arterial hypertension?

TL;DR: Four patients with severe PAH and PA dilatation in whom PA dissection has been confirmed are presented and optimal management strategies are suggested for patients with stable PAH but significantly dilated proximal pulmonary arteries or confirmedPA dissection depending on the clinical presentation and expected outcome.
Journal ArticleDOI

Functional class and type of pulmonary hypertension determinate severity of cardiac autonomic dysfunction assessed by heart rate variability and turbulence.

TL;DR: Higher WHO-FC and probably type of pulmonary hypertension (CTEPH more than PAH) determinate the severity of cANS dysfunction assessed by heart rate variability and turbulence.
Journal ArticleDOI

Role of cardiac biomarkers in assessment of RV function and prognosis in chronic pulmonary hypertension

TL;DR: Humoral biomarkers emerged within the last decade as an attractive non-invasive tool for assessment and monitoring of right ventricular dysfunction in patients with pulmonary hypertension and would be particularly useful for outpatient monitoring and daily clinical practice.
Journal ArticleDOI

Left main artery compression by pulmonary artery aneurysm and ostial athero-stenosis of left anterior descending artery in a young female with pulmonary arterial hypertension.

TL;DR: A 29-year-old patient with idiopathic pulmonary arterial hypertension treated with sildenafil, treprostinil, and nifedipine suddenly developed recurrent chest pain at rest, accompanied by an acute inversion of T-waves in V3–V6 and a troponin I increase of up to 1.9 ng/mL.